ASRT — Assertio Holdings Share Price
0.000.00%
Last trade - 00:00- $59.19m
- -$2.05m
- $124.96m
- 44
- 83
- 47
- 60
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.49 | ||
| Price to Tang. Book | 1.46 | ||
| Price to Free Cashflow | 2.24 | ||
| Price to Sales | 0.47 | ||
| EV to EBITDA | -1.83 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -14.39% | ||
| Return on Equity | -16.66% | ||
| Operating Margin | -19.59% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 106.28 | 111.01 | 156.23 | 152.07 | 124.96 | 115.25 | 128.16 | -11.45% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Assertio Holdings, Inc. is a commercial pharmaceutical company offering differentiated products to patients. The Company has built its commercial portfolio through acquisition or licensing of approved products. Its comprehensive commercial capabilities include marketing through both a sales force and a non-personal promotion model, market access through payor contracting and trade and distribution. The Company’s primary marketed products include ROLVEDONTM (eflapegrastim-xnst) injection for subcutaneous use, INDOCIN (indomethacin) Suppositories, INDOCIN (indomethacin) Oral Suspension, Sympazan (clobazam) oral film, Otrexup (methotrexate) injection for subcutaneous use, SPRIX (ketorolac tromethamine) Nasal Spray, CAMBIA (diclofenac potassium for oral solution) and Zipsor (diclofenac potassium) Liquid filled capsules. INDOCIN (indomethacin) Suppositories and INDOCIN (indomethacin) Oral Suspension products are nonsteroidal anti-inflammatory drugs (NSAID).
Directors
- Peter Staple NEC (69)
- Daniel Peisert PRE (46)
- Paul Schwichtenberg CFO (50)
- Ajay Patel SVP (37)
- Heather Mason IND (60)
- William Mckee IND (59)
- James Tyree IND (68)
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- March 13th, 2020
- Public Since
- February 12th, 1997
- No. of Shareholders
- 268
- No. of Employees
- 58
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- NASDAQ Capital Market
- Shares in Issue
- 95,773,083
- Address
- 100 S. Saunders Road, Suite 300, LAKE FOREST, 60045
- Web
- https://www.assertiotx.com/
- Phone
- +1 2244197106
- Auditors
- Grant Thornton LLP
Upcoming Events for ASRT
Q1 2025 Assertio Holdings Inc Earnings Release
Assertio Holdings Inc Annual Shareholders Meeting
Q2 2025 Assertio Holdings Inc Earnings Release
Similar to ASRT
60 Degrees Pharmaceuticals
NASDAQ Capital Market
Agriforce Growing Systems
NASDAQ Capital Market
Akari Therapeutics
NASDAQ Capital Market
Akebia Therapeutics
NASDAQ Capital Market
ASP Isotopes
NASDAQ Capital Market
FAQ
What is the Assertio Holdings share price?
As of Today at 19:22 UTC, shares in Assertio Holdings are trading at $0.62. This share price information is delayed by 15 minutes.
How has the Assertio Holdings share price performed this year?
Shares in Assertio Holdings last closed at $0.62 and the price had moved by -21.28% over the past 365 days. In terms of relative price strength the Assertio Holdings share price has underperformed the S&P500 Index by -27.34% over the past year.
What are the analyst and broker recommendations for Assertio Holdings?
The overall consensus recommendation for Assertio Holdings is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Assertio Holdings dividend yield?
Assertio Holdings does not currently pay a dividend.
Does Assertio Holdings pay a dividend?
Assertio Holdings does not currently pay a dividend.
When does Assertio Holdings next pay dividends?
Assertio Holdings does not currently pay a dividend.
How do I buy Assertio Holdings shares?
To buy shares in Assertio Holdings you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Assertio Holdings?
As of the previous close price of $0.62, shares in Assertio Holdings had a market capitalisation of $59.19m.
Where are Assertio Holdings shares listed?
Here are the trading details for Assertio Holdings:
- Country of listing: United States
- Exchange: NAQ
- Ticker Symbol: ASRT
What kind of share is Assertio Holdings?
Based on an overall assessment of its quality, value and momentum Assertio Holdings is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Assertio Holdings share price forecast for 2025?
The analyst consensus target price for shares in Assertio Holdings is $2.81. That is 354.69% above the last closing price of $0.62.
Analysts covering Assertio Holdings currently have a consensus Earnings Per Share (EPS) forecast of -$0.18 for the next financial year.
Find out moreWhat is the trend in the Assertio Holdings share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Assertio Holdings. Over the past six months, its share price has underperformed the S&P500 Index by -37.97%.
As of the last closing price of $0.62, shares in Assertio Holdings were trading -37.8% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Assertio Holdings PE Ratio?
The Assertio Holdings PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $0.62.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Assertio Holdings?
Assertio Holdings' management team is headed by:
- Peter Staple - NEC
- Daniel Peisert - PRE
- Paul Schwichtenberg - CFO
- Ajay Patel - SVP
- Heather Mason - IND
- William Mckee - IND
- James Tyree - IND